All peptides
LongevityEmerging

NAD+

Nicotinamide adenine dinucleotide

A central metabolic coenzyme injected or infused in longevity clinics; declining NAD+ is a hallmark of biological ageing.

How it works

Serves as an electron carrier in redox reactions and as the required substrate for sirtuins and PARP enzymes, which govern DNA repair and mitochondrial biogenesis.

Structure: Coenzyme (dinucleotide, not a peptide)

Reported benefits

  • Reported energy and mental-clarity improvements
  • Supports sirtuin-mediated DNA repair pathways
  • Used adjunctively in recovery clinics

Practical considerations

  • Precursors (NR, NMN) are cheaper and orally available with better human data
  • Infusions must be run slowly or they are extremely uncomfortable
  • Benefit in healthy young adults is unclear

Side effects and risks

  • Flushing, chest tightness and nausea during rapid infusion
  • Injection-site pain
  • Headache

Dosing overview

IV 250–750 mg per session; subcutaneous 50–100 mg several times weekly

This describes doses reported in published literature and community protocols. It is not a recommendation, and it is not a substitute for clinical supervision.

Research references

  • Covarrubias et al., 2021 — NAD+ metabolism in ageing, Nature Reviews